Spontaneous factor VIII inhibitor occurring in association with chronic graft‐versus‐host disease
Authors:
- 1 March 1994
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 45 (3) , 240-243
Abstract
The development of spontaneously acquired Factor VIII inhibitors is rare and may lead to serious hemorrhagic sequeiae. We report here the case of a patient who acquired a Factor VIII inhibitor two years after an allogeneic bone marrow transplant for CML. This occurred in association with a flare of chronic graft versus host dlsease (GVDH). He responded to corticosteroid therapy. A review of autoimmune phenomena associated with chronic GVDH and the treatment of Factor VIII Inhibitors is discussed.Keywords
This publication has 16 references indexed in Scilit:
- Thalidomide for the Treatment of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1992
- Obstructive Lung Disease after Allogeneic Marrow TransplantationAnnals of Internal Medicine, 1989
- Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationBlood, 1988
- Factor VIII InhibitorsAnnals of the New York Academy of Sciences, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- INTRAVENOUS IgG FOR PATIENTS WITH SPONTANEOUS INHIBITOR TO FACTOR VIIIThe Lancet, 1985
- Factor VIII inhibitors: A clinical overviewAmerican Journal of Hematology, 1982
- Chronic graft-versus-host syndrome in manThe American Journal of Medicine, 1980
- Chronic graft versus host disease: A syndrome of disordered immunityThe American Journal of Medicine, 1979
- Scleroderma, Sjögren-like Syndrome, and Chronic Graft-Versus-Host DiseaseAnnals of Internal Medicine, 1977